Jennifer Cook's Insider Trades & SAST Disclosures
Jennifer Cook's most recent trade in Denali Therapeutics Inc was a trade of 18,111 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer Cook.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 26,075 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 10,619 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.35 per share. | 02 Aug 2024 | 1,484 | 9,135 (0%) | 0% | 111.3 | 165,243 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 21.73 per share. | 06 Jun 2024 | 1,458 | 20,038 (0%) | 0% | 21.7 | 31,682 | Common Stock |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 21,496 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Cook Jennifer E. | Director | Sale of securities on an exchange or to another person at price $ 119.27 per share. | 04 Dec 2023 | 417 | 6,888 (0%) | 0% | 119.3 | 49,736 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 3,075 | 8,546 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 11 Aug 2023 | 1,241 | 7,305 (0%) | 0% | 138.2 | 171,454 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 15,529 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Sale of securities on an exchange or to another person at price $ 154.68 per share. | 02 Dec 2022 | 420 | 5,471 (0%) | 0% | 154.7 | 64,966 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,561 | 6,980 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Sale of securities on an exchange or to another person at price $ 152.32 per share. | 05 Aug 2022 | 1,089 | 5,891 (0%) | 0% | 152.3 | 165,879 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,959 | 17,959 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,986 | 11,313 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Sale of securities on an exchange or to another person at price $ 121.30 per share. | 02 Dec 2021 | 417 | 4,419 (0%) | 0% | 121.3 | 50,582 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 3,576 | 7,152 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 3,576 | 0 | - | - | Restricted Stock Units | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 2,246 | 4,836 (0%) | 0% | 0 | Ordinary Shares | |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 38,895 | 38,895 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,222 | 6,222 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,074 | 5,327 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 0 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 3,253 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 6,475 | 6,475 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharmaceuticals plc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 2,590 | 2,590 (0%) | 0% | 0 | Ordinary Shares | |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 3,576 | 3,576 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 3,576 | 3,576 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges